Synthesis and biological activities of novel β-Carbolines as PDE5 inhibitors

Bioorganic & Medicinal Chemistry Letters
2003.0

Abstract

A series of N(2)-furoyl and N(2)pyrimidinyl beta-carbolines was discovered to possess potent inhibitory activity against PDE5. During the synthesis we developed a tandem resin quenching protocol, which allowed us to synthesize large number of target compounds in a rapid fashion. Representative compounds exhibit superior selectivity to sildenafil versus other isozymes of PDEs, and demonstrated in vivo efficacy in increasing introcavernosal pressure in dogs.

Knowledge Graph

Similar Paper

Synthesis and biological activities of novel β-Carbolines as PDE5 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Furoyl and Benzofuroyl Pyrroloquinolones as Potent and Selective PDE5 Inhibitors for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry 2003.0
Discovery of furyl/thienyl β-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect
European Journal of Medicinal Chemistry 2018.0
Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
Bioorganic & Medicinal Chemistry Letters 2004.0
Pyrimidinylpyrroloquinolones as Highly Potent and Selective PDE5 Inhibitors for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry 2002.0
The Discovery of Tadalafil:  A Novel and Highly Selective PDE5 Inhibitor. 1: 5,6,11,11a-Tetrahydro-1H-imidazo[1‘,5‘:1,6]pyrido[3,4-b]indole-1,3(2H)-dione Analogues
Journal of Medicinal Chemistry 2003.0
Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction
Bioorganic & Medicinal Chemistry Letters 2008.0
Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors
European Journal of Medicinal Chemistry 2018.0
2-Phenylquinazolin-4(3H)-one, a class of potent PDE5 inhibitors with high selectivity versus PDE6
Bioorganic & Medicinal Chemistry Letters 2009.0
Structure−Activity Relationships of N-Acyl Pyrroloquinolone PDE-5 Inhibitors
Journal of Medicinal Chemistry 2004.0